Expression of type I and II interferon (IFN) was evaluated in gut-associated lymphoid tissue (GALT) and peripheral blood mononuclear cells (PBMCs) of HIV-1-positive patients on long-term, suppressive, antiretroviral therapy before and after probiotic supplementation. IFNα subtypes and IFNβ were expressed at higher levels in GALT compared to PBMC, whereas an opposite trend of expression was recorded for IFNγ. An increase of IFNα6, IFNα10, IFNα14, IFNα17, and IFNα21 and a decrease of IFNγ were observed in both anatomical sites after probiotic supplementation.

Type I/II interferon in HIV-1-infected patients: expression in gut mucosa and in peripheral blood mononuclear cells and its modification upon probiotic supplementation / Pinacchio, Claudia; Corano Scheri, Giuseppe; Statzu, Maura; Santinelli, Letizia; Ceccarelli, Giancarlo; Innocenti, Giuseppe Pietro; Vullo, Vincenzo; Antonelli, Guido; Brenchley, Jason M.; D’Ettorre, Gabriella; Scagnolari, Carolina. - In: JOURNAL OF IMMUNOLOGY RESEARCH. - ISSN 2314-8861. - STAMPA. - 2018(2018), pp. 1-7. [10.1155/2018/1738676]

Type I/II interferon in HIV-1-infected patients: expression in gut mucosa and in peripheral blood mononuclear cells and its modification upon probiotic supplementation

Pinacchio, Claudia
Methodology
;
Corano Scheri, Giuseppe
Membro del Collaboration Group
;
STATZU, MAURA
Membro del Collaboration Group
;
SANTINELLI, LETIZIA
Methodology
;
Ceccarelli, Giancarlo
Conceptualization
;
Vullo, Vincenzo
Membro del Collaboration Group
;
ANTONELLI, Guido
Conceptualization
;
d’Ettorre, Gabriella
Conceptualization
;
SCAGNOLARI, CAROLINA
2018

Abstract

Expression of type I and II interferon (IFN) was evaluated in gut-associated lymphoid tissue (GALT) and peripheral blood mononuclear cells (PBMCs) of HIV-1-positive patients on long-term, suppressive, antiretroviral therapy before and after probiotic supplementation. IFNα subtypes and IFNβ were expressed at higher levels in GALT compared to PBMC, whereas an opposite trend of expression was recorded for IFNγ. An increase of IFNα6, IFNα10, IFNα14, IFNα17, and IFNα21 and a decrease of IFNγ were observed in both anatomical sites after probiotic supplementation.
File allegati a questo prodotto
File Dimensione Formato  
Pinacchio_Type-I/II-interferon_2018.pdf

accesso aperto

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Creative commons
Dimensione 1.7 MB
Formato Adobe PDF
1.7 MB Adobe PDF Visualizza/Apri PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11573/1136175
Citazioni
  • ???jsp.display-item.citation.pmc??? 5
  • Scopus 11
  • ???jsp.display-item.citation.isi??? 11
social impact